Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

August 01, 2005 (Vol. 25, No. 14)

Innovative Antibody Products and Therapeutics

Improving Selection and Affinity

  • At a recent CHI meeting in Cambridge, MA, "Recombinant Antibodies from Concept to Clinic", a wide range of new antibody technologies were covered. Dana Ault-Rich, Ph.D., CEO of Pointilliste (Mountain View, CA), discussed the company's innovative technology and its application to the isolation of new therapeutic antibodies directed against ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.